Investors

Investor Relations

Landing - Corporate Profile Text

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events

More events are coming soon.

News Releases

June 10, 2021
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June
NEW YORK and VIENNA, Austria, June 10, 2021 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate and present at the